Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ferric Derisomaltose for Anemia in ED
NCT05304442Phase 3Recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2022
- Primary completion
- Mar 2025
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by Baylor College of Medicine. Started Sep 2022; status: recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05304442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05304442.